Dopamine – Indications, Mode of Use and Side Effects
Dopamine Indications: Dopamine indications arefor some types of shock accompanied by oliguria and low or normal peripheral vascular resistance. Cardiogenic and bacteraemic shock, Severe hypotension followed by removal of the pheochromocytoma. Dopamine hydrochlorideis indicated for the correction of hemodynamic imbalance resulting from shock of multiple etiologies, trauma and/or hemorrhage , endotoxic septicemia, drug intoxication, postoperative, particularly cardiac, and low output syndrome. It is also indicated for the preoperative preparation of high-risk patients, treatment of renal failure and hydrosaline retention of multiple etiologies.
Dopamine Contraindications: Dopamine cannot beused during pregnancy , in patients with pheochromocytoma, tachyarrhythmias or ventricular fibrillation, in patients undergoing treatment with a hand inhibitor or tricyclic antidepressants. The safety and effectiveness of using dopamine in children has not yet been established. It should not be given together with sodium bicarbonate or other intravenous alkaline solutions.
Dopamine Side Effects: The adverse effects of dopamine are:
- Arrhythmia
- Tachycardia
- bradycardia
- Palpitations
- Chest pain
- Shortness of breathe
- Hypertension
- hypotension
- Headache
- seasickness
- vomit
- vasoconstriction
- vascular stasis
- Intumcência
- Tingling
- Pain in hands or feet.
Dopamine Usage Mode: According to medical recommendations for dopamine use ; Adults and children: from 1 to 5 µg/kg/min in continuous infusion, reaching 50 µg/kg/min. Babies: from 1 to 20µg/kg/min in continuous infusion. The dose can be changed as needed.
Dopamine should not be given to patients allergic to sulfites as it contains bisulfite in its vehicle. Patients with a history of peripheral vascular disease secondary to atherosclerosis, diabetes, or Raynaud’s disease are at increased risk of ischemia of the extremities. The vasoconstrictor properties of dopamine prevent its administration by the subcutaneous or intramuscular route. The product is inactivated when administered orally.